Ulland Investment Advisors, LLC - GEMINI THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Ulland Investment Advisors, LLC ownership history of GEMINI THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q3 2022$1,0000.0%3480.0%0.00%0.0%
Q2 2022$1,0003480.0%0.00%
Q1 2022$0
-100.0%
3480.0%0.00%
-100.0%
Q4 2021$1,0003480.00%
Other shareholders
GEMINI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Opportunity Management V, LLC 2,435,125$3,385,0004.74%
Foresite Capital Management V, LLC 2,435,125$3,385,0001.38%
Atlas Venture Life Science Advisors, LLC 5,254,365$7,304,0000.92%
Orbimed Advisors 5,826,224$8,098,0000.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 2,372,267$3,297,0000.10%
Boxer Capital, LLC 1,300,000$1,807,0000.09%
Ikarian Capital, LLC 443,096$615,0000.08%
HARVARD MANAGEMENT CO INC 250,000$348,0000.04%
PURA VIDA INVESTMENTS, LLC 496,120$690,0000.02%
Marquette Asset Management, LLC 66,269$92,0000.02%
View complete list of GEMINI THERAPEUTICS INC shareholders